- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Malignant Melanoma in Canada
Total 426 results
-
National Cancer Institute (NCI)Active, not recruitingSarcoma | Metastatic Renal Cell Carcinoma | Metastatic Melanoma | Recurrent Renal Cell Carcinoma | Recurrent Melanoma | Stage IV Renal Cell Cancer AJCC v8 | Metastatic Malignant Solid Neoplasm | Metastatic Colorectal Carcinoma | Stage IV Colorectal Cancer AJCC v8 | Clinical Stage IV Cutaneous Melanoma... and other conditionsUnited States, Canada
-
Genta IncorporatedCompletedMelanomaUnited States, France, United Kingdom, Spain, Switzerland, Australia, Canada, Germany, Poland, Italy, Austria, Czech Republic
-
Saint John's Cancer InstituteNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedMelanomaUnited States, Australia, Italy, Spain, Canada, Netherlands, Germany, Finland, Israel, Sweden, Switzerland, United Kingdom
-
Hoffmann-La RocheCompletedMetastatic CancersSpain
-
University Health Network, TorontoCanadian Association of Radiation OncologyCompleted
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Metastatic Malignant Neoplasm in the Liver | Unresectable Solid NeoplasmUnited States, Canada
-
University of SaskatchewanCompleted
-
McGill University Health Centre/Research Institute...Unknown
-
Formation BiologicsUnknownMalignant Solid TumorUnited States, Canada
-
Celgene CorporationCompletedMelanoma | Neoplasm MetastasisUnited States, Canada
-
Ottawa Hospital Research InstituteUnknownMalignant Pleural EffusionCanada
-
University of AlbertaCapital Health, CanadaCompletedMalignant Gliomas, Glioblastoma MultiformeCanada
-
University Health Network, TorontoActive, not recruiting
-
Bristol-Myers SquibbActive, not recruitingMelanomaItaly, Poland, United States, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Germany, Greece, Netherlands, Norway, Romania, Spain, Switzerland, United Kingdom, Sweden
-
Canadian Cancer Trials GroupNovartisTerminatedMelanoma | Brain MetastasesCanada
-
Genentech, Inc.Active, not recruitingMelanomaUnited States, Germany, Australia, Korea, Republic of, Canada, Norway
-
Merck Sharp & Dohme LLCActive, not recruitingMelanomaCanada, United States, Australia, Belgium, Brazil, Chile, France, Germany, Israel, Italy, Japan, Poland, South Africa, Spain, Switzerland, United Kingdom
-
Hoffmann-La RocheCompletedMelanomaUnited States, Israel, Italy, Spain, Belgium, United Kingdom, Austria, Czechia, France, Netherlands, New Zealand, Russian Federation, Australia, Canada, Croatia, Portugal, Germany, Ukraine, Switzerland, Argentina, Brazil, Ireland, N... and more
-
Ontario Clinical Oncology Group (OCOG)Novartis PharmaceuticalsTerminatedAdvanced Malignant Pleural Mesothelioma | MPMCanada
-
Hoffmann-La RocheRecruitingMelanomaBrazil, Czechia, Spain, Turkey, New Zealand, Canada, Australia, Poland, Slovakia, Greece
-
Bristol-Myers SquibbCompletedMelanoma | Skin CancerUnited States, Canada, Netherlands, Spain, Australia, Italy, Japan, Germany, Ireland, United Kingdom, Czechia, Switzerland, Poland, France, Greece, New Zealand
-
POINT BiopharmaActive, not recruitingSoft Tissue Sarcoma | Colorectal Cancer | Esophageal Cancer | Cholangiocarcinoma | Head and Neck Squamous Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Melanoma (Skin)United States, Canada
-
Novartis PharmaceuticalsCompletedMelanoma and Brain MetastasesCanada, United States, Australia, France, Germany, Italy, Spain
-
University of British ColumbiaCompletedMalignant Tumor of Extrahepatic Bile DuctCanada
-
PfizerCompletedMelanomaUnited States, Australia, Canada, Germany, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
GlaxoSmithKlineCompletedMelanoma and Brain MetastasesAustralia, Germany, United States, Canada, Italy, France
-
Grupo Español Multidisciplinar de MelanomaPierre Fabre Medicament; MFARActive, not recruitingMetastatic Melanoma | Brain MetastasesSpain
-
AdaptimmuneCompletedMelanoma | Head and Neck Cancer | Urothelial Carcinoma | Bladder Urothelial CarcinomaUnited States, Canada, Spain
-
Sunnybrook Health Sciences CentreEnhanced Medical Nutrition; Sunnybrook Health Sciences Centre Clinical Research... and other collaboratorsCompletedSurgery | Hepatopancreaticobiliary (HPB) MalignancyCanada
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedSarcoma | Unspecified Childhood Solid Tumor, Protocol Specific | Neuroblastoma | Melanoma (Skin)United States, Canada, Australia
-
McMaster UniversityCompletedSurgery | Venous Thromboembolism | Adherence, Medication | Prophylaxis | Neoplasms MalignantCanada
-
McGill University Health Centre/Research Institute...ASGECompletedMALIGNANT GASTROINTESTINAL BLEEDINGCanada
-
SanofiCompletedNeoplasm MalignantCanada, United States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingMelanomaArgentina, United States, Australia, Austria, Belgium, Canada, Czechia, Finland, France, Greece, Hungary, Ireland, Italy, Japan, Korea, Republic of, Netherlands, Norway, Poland, Romania, South Africa, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
Lawson Health Research InstituteUnknownMalignant Hematologic NeoplasmCanada
-
University Health Network, TorontoRecruitingCancer | Breast Cancer | Colorectal Cancer | Non-small Cell Lung Cancer | Melanoma (Skin) | Genitourinary Cancer | Gynecological Cancer | Rare Cancer | Carcinoma of Unknown Primary | Pancreatobiliary Gastrointestinal Cancer | Upper Aerodigestive Tract CancerCanada
-
SanofiActive, not recruitingNeoplasm MalignantUnited States, Canada, France, Korea, Republic of, Spain
-
AmgenMerck Sharp & Dohme LLCCompletedMelanomaUnited States, Canada, Spain, France, Australia, Greece, Italy, United Kingdom, Germany, Netherlands, Poland
-
Bristol-Myers SquibbRecruitingMelanomaUnited States, Canada, Switzerland, Italy, Spain, Australia, France, Belgium, Finland, Israel, Germany, Sweden, Argentina, Brazil, Colombia, Mexico, Norway, Chile, United Kingdom, Austria, Poland, Czechia
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom
-
Bristol-Myers SquibbCompletedMelanoma | MetastasesUnited States, Canada, Netherlands, United Kingdom, Germany, Chile, Belgium, France, South Africa, Argentina, Brazil, Hungary, Switzerland
-
AHS Cancer Control AlbertaCompleted
-
AHS Cancer Control AlbertaCompleted
-
NRG OncologyNational Cancer Institute (NCI)TerminatedPleural Biphasic Mesothelioma | Pleural Epithelioid Mesothelioma | Stage I Pleural Malignant Mesothelioma AJCC v8 | Stage IA Pleural Malignant Mesothelioma AJCC v8 | Stage IB Pleural Malignant Mesothelioma AJCC v8 | Stage II Pleural Malignant Mesothelioma AJCC v8 | Stage IIIA Pleural Malignant...United States, Canada
-
University Health Network, TorontoRecruiting
-
Regeneron PharmaceuticalsRecruitingMelanomaUnited States, Australia, Spain, United Kingdom, Canada, Brazil, Mexico, Germany, Ireland, South Africa, France, Israel, Georgia, Turkey, Italy, Poland, Chile, Argentina, Belgium, Czechia, Romania, Greece
-
AmgenRecruitingMelanomaItaly, Spain, Czechia, Serbia, Estonia, Bosnia and Herzegovina, Portugal, Romania, Georgia, Lithuania, Malaysia, United States, Taiwan, France, Canada, Thailand, Croatia, Mexico, Germany, Philippines
-
Hoffmann-La RocheActive, not recruitingMelanomaUnited States, Korea, Republic of, United Kingdom, Australia, France, Belgium, Italy, Portugal, Spain, Brazil, Canada, Russian Federation, Germany, New Zealand, Israel, Poland, Greece, Austria, Hungary, Netherlands
-
British Columbia Cancer AgencyBC Cancer FoundationCompletedGastrointestinal Stromal Tumors | Colorectal Cancer Metastatic | Advanced Melanoma | Advanced Non-Small Cell Lung Carcinoma | Patients With Diagnosed Malignancies Being Considered for Clinical TrialsCanada
-
AHS Cancer Control AlbertaNot yet recruitingDiarrhea | Advanced Melanoma | Immune-related Adverse Event | Advanced Rectal CarcinomaCanada